BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy
Biosensors and Bioelectronics · 2024
DOI: 10.1016/j.bios.2023.115895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Mingyang Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Micro/Nano Biosensing, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Combined photothermal therapy and nitric oxide (NO)-mediated gas therapy has shown great potential as a cancer treatment. However, the on-demand release of NO at a high concentration presents a challenge owing to the lack of an ideal bio-transducer with a high loading capacity of NO donors and sufficient energy to induce NO release. Here, we present a new 2D BiTiS3 nanosheet that is synthesized, loaded with the NO donor (BNN6), and conjugated with PEG-iRGD to produce a multifunctional bio-transducer (BNN6-BiTiS3-iRGD) for the on-demand production of NO. The BiTiS3 nanosheets not only have a high loading capacity of NO donors (750%), but also exhibit a high photothermal conversion efficiency (59.5%) after irradiation by a 1064-nm laser at 0.5 W/cm2. As a result of the above advantages, the temporal-controllable generation of NO within a large dynamic range (from 0 to 344 μM) is achieved by adjusting power densities, which is among the highest efficiency values reported for NO generators so far. Moreover, the targeted accumulation of BNN6-BiTiS3-iRGD at tumor sites leads to spatial-controllable NO release. In vitro and in vivo assessments demonstrate synergistic NO gas therapy with mild photothermal therapy based on BNN6-BiTiS3-iRGD. Our work provides insights into the design and application of other 2D nanomaterial-based therapeutic platforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Micro/Nano Biosensing, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.
- Department of Applied Physics, School of Science, East China Jiaotong University, Nanchang, 330013, China.
- Department of Physics, Department of Materials Science and Engineering, and Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong.
- Shenzhen Key Laboratory of Micro/Nano Biosensing, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. Electronic address: jh.wang1@siat.ac.cn.
- Shenzhen Key Laboratory of Micro/Nano Biosensing, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. Electronic address: wh.zhou@siat.ac.cn.
- Shenzhen Key Laboratory of Micro/Nano Biosensing, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. Electronic address: sy.geng@siat.ac.cn.
Zitieren
APA
Jiang, M., Cheng, Z., Luo, T., Chu, C., Zhang, Z., Hui, Y., Chu, P. K., Yu, X. F., Wang, J., Zhou, W., & Geng, S. (2024). BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115895
Vancouver
Jiang M, Cheng Z, Luo T, Chu C, Zhang Z, Hui Y, et al. BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2023.115895
BibTeX
@article{Jiang2024,
author = {Jiang, Mingyang and Cheng, Ziqiang and Luo, Tingting and Chu, Chenchen and Zhang, Zhenyu and Hui, Yun and Chu, Paul K and Yu, Xue-Feng and Wang, Jiahong and Zhou, Wenhua and Geng, Shengyong},
title = {BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy},
journal = {Biosensors and Bioelectronics},
year = {2024},
doi = {10.1016/j.bios.2023.115895}
}
EUVIMED